Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$50,000.00
Jun 2, 2021
For-profit organization
Production Support Engineer
979080
Development and implementation of CANImmunize ClinicFlow to support the COVID-19 vaccine rollout in Canada.
$500,000.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161625
Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.
$496,871.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161628
Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.
$495,000.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161626
Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.
$496,134.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161633
Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.
$3,071,774.00
Jun 1, 2021
For-profit organization
COVID-19 Response (VI): STAGE 2 Oral DNA Vaccine Development
974484
This project will involve further development and characterization of oral bacTRL-based vaccines. This work includes the preclinical development of additional bacTRL-based products including emergent or predicted SARS-CoV-2 variants, as well as the continued evaluation of the lead vaccine candidate in a Phase I clinical trial.
$34,800.00
Jun 1, 2021
For-profit organization
Development of grapevine leafroll-associated virus 3 (GLRaV-3) vaccine
973465
The attenuated grapevine leafroll-associated virus 3 will be developed by mutagenesis and tested for protection of GLRaV-3 free tissue culture against the infection of wild-type GLRaV-3 in the field.
$499,416.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161630
Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.
$499,900.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161627
Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.
$404,547.00
Jun 1, 2021
Individual or sole proprietorship
Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines
161623
Please note that to be eligible to the competition applications must address both objectives AND respond to at least one (1) of the fifteen (15) subtopics under the six (6) research areas.
The specific objectives of this funding opportunity are to:
1. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; and inform actions for future pandemic; and
2. Generate evidence related to one or more diverse population(s), including for instance: health equity considerations, health status (e.g. high risk populations, individuals with comorbid conditions), sex and gender, a life cycle approach (from children to aging adults), and/or racialized or First Nations, Inuit, Metis and Urban Indigenous populations.
Note: It is expected that, where appropriate, projects will enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.